+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Soft Tissue Repair Market Report Suite with COVID Impact- United States - 2020-2026 - MedSuite

  • ID: 5019858
  • Report
  • March 2020
  • Region: United States
  • iData Research

FEATURED COMPANIES

  • Abbott
  • AxoGen
  • Cryolife
  • Geistlich Pharma
  • LifeNet Health
  • Osteogenics
Throughout this medical market research, the publisher analyzed 37 soft tissue repair device companies in the US and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the US Soft Tissue Repair market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a soft tissue repair procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered
  • Soft Tissue Repair Procedure Volumes in the US– MedPro
  • Breast Reconstruction Market - MedCore
  • Hernia Repair Market - MedCore
  • Dural Repair Market - MedCore
  • Dental Soft Tissue Repair Market - MedCore
  • Nerve Repair Market - MedCore
  • Cardiovascular Repair Market - MedCore

US Soft Tissue Repair Devices Market Insights

Soft tissue repair devices add significant costs to suture-based repair procedures. The cost varies, depending on the type of device used and the repair being performed, but, in general, biological devices, such as allografts and xenografts, cost significantly more than synthetic devices within the same market segment. For example, biological devices may offer superior long-term benefits in hernia repair by avoiding risks of infection and premature degradation and failure, but their high cost continues to deter surgeons from using them

The changing demographics in the U.S. has a very favorable effect on the soft tissue repair market. The growing elderly and obese populations have a higher risk of a number of different medical conditions, including hernias and nerve damage. Between 2010 and 2025, the total number of people with diabetes in the U.S. is expected to increase by 64%.

Overall, the U.S. soft tissue repair market was valued at $1.8 billion in 2019. This is expected to increase over the forecast period at a CAGR of 7.8% to reach $3.1 billion.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • AxoGen
  • Cryolife
  • Geistlich Pharma
  • LifeNet Health
  • Osteogenics
List of Figures

List of Charts

Executive Summary

U.S. Soft Tissue Repair Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Markets Included

Key Report Updates

Version History

Research Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

U.S. Soft Tissue Repair Market Overview
2.1 Introduction
2.2 Market Overview
2.3 Trend Analysis by Segment
2.4 Drivers and Limiters
2.4.1 Market Drivers
2.4.2 Market Limiters
2.5 Competitive Market Share Analysis
2.6 Mergers and Acquisitions

Procedure Numbers
3.1 Procedures
3.1.1 Breast Reconstruction Procedures
3.1.2 Hernia Repair Procedures
3.1.3 Dural Repair Procedures
3.1.4 Dental Soft Tissue Regeneration Procedures
3.1.5 Cardiovascular Repair Procedures
3.1.6 Nerve Repair Procedures

Breast Reconstruction Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis and Forecast
4.3.1 Breast Reconstruction Market
4.3.1.1 Allograft Breast Reconstruction Market
4.3.1.2 Xenograft Breast Reconstruction Market
4.3.1.3 Synthetic Breast Reconstruction Market
4.4 Drivers and Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

Hernia Repair Market
5.1 Introduction
5.2 Market Overview
5.2.1 Hernia Repair Market Overview by Segment
5.2.2 Hernia Repair Market Overview by Material
5.3 Market Analysis and Forecast
5.3.1 Hernia Repair Market
5.3.2 Ventral Hernia Repair Market
5.3.2.1 Allograft Ventral Hernia Repair Market
5.3.2.2 Xenograft Ventral Hernia Repair Market
5.3.2.3 Reinforced Xenograft Ventral Hernia Repair Market
5.3.2.4 Non-Reinforced Xenograft Ventral Hernia Repair Market
5.3.2.5 Synthetic Ventral Hernia Repair Market
5.3.2.6 Resorbable Synthetic Ventral Hernia Repair Market
5.3.2.7 Non-Resorbable Synthetic Ventral Hernia Repair Market
5.3.3 Inguinal Hernia Repair Market
5.3.3.1 Allograft Inguinal Hernia Repair Market
5.3.3.2 Xenograft Inguinal Hernia Repair Market
5.3.3.3 Synthetic Inguinal Hernia Repair Market
5.3.4 Hiatal Hernia Repair Market
5.3.4.1 Allograft Hiatal Hernia Repair Market
5.3.4.2 Xenograft Hiatal Hernia Repair Market
5.3.4.3 Reinforced Xenograft Hiatal Hernia Repair Market
5.3.4.4 Non-Reinforced Xenograft Hiatal Hernia Repair Market
5.3.4.5 Synthetic Hiatal Hernia Repair Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
5.5.1 Total Hernia Repair Market
5.5.2 Ventral Hernia Repair Market
5.5.2.1 Xenograft Ventral Hernia Repair Market
5.5.2.2 Synthetic Ventral Hernia Repair Market
5.5.3 Inguinal Hernia Repair Market
5.5.4 Hiatal Hernia Repair Market
5.5.4.1 Xenograft Hiatal Hernia Repair Market

Dural Repair Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Dural Repair Market
6.3.2 Allograft Dural Repair Market
6.3.3 Xenograft Dural Repair Market
6.3.4 Synthetic Dural Repair Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Dental Soft Tissue Regeneration Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Dental Soft Tissue Regeneration Market
7.3.1.1 Allograft Dental Soft Tissue Regeneration Market
7.3.1.2 Xenograft Dental Soft Tissue Regeneration Market
7.3.1.3 Dental Wound Care Market
7.3.1.4 Plug Dental Wound Care Market
7.3.1.5 Tape Dental Wound Care Market
7.3.1.6 Foam Dental Wound Care Market
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

Nerve Repair Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Nerve Repair Market
8.3.2 Nerve Wrap Market
8.3.3 Nerve Graft Market
8.3.4 Nerve Tube Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

Cardiovascular Repair Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Cardiac Patch Market
9.3.1.1 Xenograft Cardiac Patch Market
9.3.1.2 Allograft Cardiac Patch Market
9.3.1.3 Synthetic Cardiac Patch Market
9.3.2 Vascular Patch Market
9.3.2.1 Xenograft Vascular Patch Market
9.3.2.2 Synthetic Vascular Patch Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

Abbreviations
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott
  • Ace Surgical
  • ACell
  • Admedus
  • Aesculap
  • Allergan
  • AxoGen
  • Baxter
  • Becton Dickinson
  • Citagenix
  • Cook Medical
  • CorMatrix
  • Cryolife
  • DePuy Synthes
  • DynaMesh
  • Edwards LifeSciences
  • Ethicon
  • Galatea Surgical
  • Geistlich Pharma
  • Getinge
  • Gore
  • Henry Schein
  • Integra LifeSciences
  • LeMaitre Vascular
  • LifeNet Health
  • Mast BioSurgery
  • Medtronic
  • MTF
  • Natus Medical
  • Novus Medical
  • Osteogenics
  • RTI Surgical
  • Stryker
  • TELA Bio
  • Tissue Regenix
  • Xtant Medical
  • Zimmer Biomet
Note: Product cover images may vary from those shown